Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

prasugrel

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of prasugrel

35 trials tracked of prasugrel: 20 in phase 3 or 4 and 9 with published results. The most-cited published study has 658 citations.

35Trials tracked

20Phase 3 & 4

0Recruiting

9With published results

Phase distribution

Phase 4 13 Phase 3 7 Phase 2 8 Phase 1 4 Other / NA 3

Phase 3 Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Completed · 658 cited
Phase 4 Pharmacological Effects of Crushing Prasugrel in STEMI Patients Completed · 123 cited
Phase 3 A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention Completed · 74 cited
Phase 4 A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function: Completed · 27 cited
Phase 4 Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor Completed · 22 cited
Phase 4 Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI Completed · 20 cited

Show 29 more trials

Phase 4 Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI) Completed · 15 cited
Phase 4 Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Completed · 10 cited
Phase 4 Clopidogrel Monotherapy in Patients With High Bleeding Risk Completed · 1 cited
Phase 4 Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation Completed
Phase 4 P3AMI Antiplatelet Trial Completed
Phase 4 Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study Completed
Phase 4 Prasugrel Re-load Strategies Completed
Phase 4 Prasugrel/Clopidogrel Maintenance Dose Washout Study Completed
Phase 4 The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease Completed
Phase 3 Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis Completed
Phase 3 A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome Completed
Phase 3 A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction Completed
Phase 3 A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention Completed
Phase 3 A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects Completed
Phase 2 Cangrelor to Clopidogrel or Prasugrel Transition Study Completed
Phase 2 Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting Completed
Phase 2 Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients Completed
Phase 2 Prasugrel Versus Placebo in Adult Sickle Cell Disease Completed
Phase 2 Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) Completed
Phase 2 Cangrelor Prasugrel Transition Study Completed
Phase 2 A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease Completed
Phase 2 The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS) Completed
Phase 1 Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease Completed
Phase 1 An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults Completed
Phase 1 Study of Prasugrel in Korean Healthy Male Volunteers Completed
Phase 1 Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease Completed
N/A Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes Completed
N/A TAXUS Libertē Post Approval Study Completed
N/A Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease Completed

Showing the 35 most-cited and recently-updated of 35 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.